Clinical Trial Update: Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of DMXAA (ASA404) in combination with chemotherapy for advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DMXAA (ASA404) (5,6-dimethylxanthenone-4-acetic acid)

Snippet

Sponsor: Antisoma Research | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED